BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3009599)

  • 1. Low-renin primary hypertension in a young patient treated with dexamethasone.
    Tommaselli AP; De Simone G; Di Lorenzo L; Rossi R; Cocca A; Valentino R; Biondi B; Lombardi G
    J Endocrinol Invest; 1986 Feb; 9(1):77-81. PubMed ID: 3009599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.
    Sutherland DJ; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1966 Nov; 95(22):1109-19. PubMed ID: 4288576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New studies of the 11 beta-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia.
    Levine LS; Rauh W; Gottesdiener K; Chow D; Gunczler P; Rapaport R; Pang S; Schneider B; New MI
    J Clin Endocrinol Metab; 1980 Feb; 50(2):258-63. PubMed ID: 6243663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1014-22. PubMed ID: 4298943
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
    Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension.
    New MI; Peterson RE; Saenger P; Levine LS
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1283-93. PubMed ID: 187612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study].
    Jeunemaitre X; Charru A; Pascoe L; Guyene TT; Aupetit-Faisant B; Shackleton CH; Schambelan M; Plouin PF; Corvol P
    Presse Med; 1995 Sep; 24(27):1243-8. PubMed ID: 7501605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autopsy case of 17 alpha-hydroxylase deficiency with malignant hypertension.
    Morimoto I; Maeda R; Izumi M; Ishimaru T; Nishimori I; Nagataki S
    J Clin Endocrinol Metab; 1983 May; 56(5):915-9. PubMed ID: 6300176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic defect of aldosterone synthesis in dexamethasone-responsive hypertension with suppressed renin and aldosterone.
    Hsieh BS; Chen FW; Chen WY
    Taiwan Yi Xue Hui Za Zhi; 1979 Apr; 78(4):388-96. PubMed ID: 288834
    [No Abstract]   [Full Text] [Related]  

  • 11. Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.
    Oberfield SE; Levine LS; Stoner E; Chow D; Rauh W; Greig F; Lee SM; Lightner E; Witte M; New MI
    J Clin Endocrinol Metab; 1981 Jul; 53(1):158-64. PubMed ID: 7016891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone suppression with dopamine infusion in low-renin hypertension.
    Holland OB; Thomas C; Brown H; Schindewolf D; Hillier Y; Gomez-Sanchez C
    J Clin Invest; 1983 Sep; 72(3):754-66. PubMed ID: 6309909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma and urine steroids in essential hypertension with normal and suppressed renin and in primary hyperaldosteronism. Changes after ACTH stimulation].
    Horký K; Tomsová Z; Gregorová I
    Cas Lek Cesk; 1980 May; 119(20-21):567-74. PubMed ID: 6250700
    [No Abstract]   [Full Text] [Related]  

  • 16. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
    Gill JR; Bartter FC
    J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
    Grim CE; Weinberger MH
    Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low renin essential hypertension in a child.
    Leumann EP; Nussberger J; Vetter W
    Helv Paediatr Acta; 1976 Jan; 30(4-5):357-63. PubMed ID: 1245435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia.
    Rösler A; Levine LS; Schneider B; Novogroder M; New MI
    J Clin Endocrinol Metab; 1977 Sep; 45(3):500-12. PubMed ID: 198425
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial.
    Calhoun DA; White WB; Krum H; Guo W; Bermann G; Trapani A; Lefkowitz MP; Ménard J
    Circulation; 2011 Nov; 124(18):1945-55. PubMed ID: 21986283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.